Dr. McGinnis earned his BS degree from Lafayette College in 2009 and his MS and PhD degrees from the University of Michigan in 2012 and 2013. He has led cross-disciplinary research teams at health technology start-ups and in academia to advance his translational research agenda which pairs innovations in wearable and mobile technologies with his expertise in biomedical signal processing, machine learning, biomechanics, and computational dynamics for the development and validation of novel digital biomarkers and therapeutics. In support of this research agenda, Dr. McGinnis has published over 85 peer-reviewed articles and has presented at national and international conferences (see CV). Many of his studies have been conducted with collaborators across a wide array of disciplines including neurology, physical therapy, mental health, and orthopedics. His work has been commercialized to form the heart of product offerings from seven companies, and he currently serves as a scientific advisor for several companies operating in the health technology space. His current efforts are focused on developing new digital therapeutics for improving the mobility and functional independence of individuals living with multiple sclerosis and Parkinson's disease, optimizing orthopedic rehabilitation outcomes, and addressing mental health problems in children and young adults.